Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens

Clinical Endocrinology

Volumn 66, Issue 6, 2007, Pages 778-788

  Kamenicky, Peter ^a,c   Houdoin, Laurence ^a   Ferlicot, Sophie ^a,b   Salenave, Sylvie ^a   Brailly, Sylvie ^a,b,c   Droupy, Stéphane ^a,b   Meduri, Geri ^c   Sasano, Hironobu ^d   Suzuki, Takashi ^d   Young, Jacques ^a,b,c   Chanson, Philippe ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM   (France)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CYTOCHROME P450 17; HYDROCORTISONE; PRASTERONE SULFATE; TESTOSTERONE;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ANDROGEN RELEASE; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; IMMUNOHISTOCHEMISTRY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; TUMOR DIAGNOSIS;

ADENOMA; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE SULFATE; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; GONADOTROPINS, PITUITARY; HUMANS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TESTOSTERONE;

EID: 34347368736     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02810.x     Document Type: Article

References (46)

1. Yamaji, T. Ibayashi, H. (1969) Plasma dehydroepiandrosterone sulfate in normal and pathological conditions. Journal of Clinical Endocrinology and Metabolism, 29, 273 278.
2. Yamaji, T., Ishibashi, M., Sekihara, H., Itabashi, A. Yanaihara, T. (1984) Serum dehydroepiandrosterone sulfate in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 59, 1164 1168.
3. Nawata, H., Higuchi, K., Yanase, T., Takayanagi, R., Kato, K. Ibayashi, H. (1985) Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome. Endocrinologia Japonica, 32, 691 700.
4. Morio, H., Terano, T., Yamamoto, K., Tomizuka, T., Oeda, T., Saito, Y., Tamura, Y. Sasano, H. (1996) Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor. Endocrine Journal, 43, 387 396.
5. Vaitukaitis, J.L., Dale, S.L. Melby, J.C. (1969) Role of ACTH in the secretion of free dehydroepiandrosterone and its sulfate ester in man. Journal of Clinical Endocrinology and Metabolism, 29, 1443 1447.
6. Arlt, W. Stewart, P.M. (2005) Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinology and Metabolism Clinics of North America, 34, 293 313, viii.
7. Sasano, H., Sato, F., Shizawa, S., Nagura, H. Coughtrie, M.W. (1995) Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland. Modern Pathology, 8, 891 896.
8. Osella, G., Terzolo, M., Borretta, G., Magro, G., Ali, A., Piovesan, A., Paccotti, P. Angeli, A. (1994) Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). Journal of Clinical Endocrinology and Metabolism, 79, 1532 1539.
9. Terzolo, M., Ali, A., Osella, G., Reimondo, G., Pia, A., Peretti, P., Paccotti, P. Angeli, A. (2000) The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. European Journal of Endocrinology, 142, 611 617.
10. Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y. Bornstein, S.R. (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Reviews, 25, 309 340.
11. Levine, A.C., Mitty, H.A. Gabrilove, J.L. (1988) Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma. The Journal of Urology, 140, 11 15.
12. Orth, D.N. (1995) Cushing's syndrome. The New England Journal of Medicine, 332, 791 803.
13. Terzolo, M., Osella, G., Ali, A., Borretta, G., Cesario, F., Paccotti, P. Angeli, A. (1998) Subclinical Cushing's syndrome in adrenal incidentaloma. Clinical Endocrinology, 48, 89 97.
14. Mantero, F., Terzolo, M., Arnaldi, G., Osella, G., Masini, A.M., Ali, A., Giovagnetti, M., Opocher, G. Angeli, A. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism, 85, 637 644.
15. Flecchia, D., Mazza, E., Carlini, M., Blatto, A., Olivieri, F., Serra, G., Camanni, F. Messina, M. (1995) Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clinical Endocrinology, 42, 129 134.
16. Bencsik, Z., Szabolcs, I., Kovacs, Z., Ferencz, A., Voros, A., Kaszas, I., Bor, K., Gonczi, J., Goth, M., Kovacs, L., Dohan, O. Szilagyi, G. (1996) Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors. Journal of Clinical Endocrinology and Metabolism, 81, 1726 1729.
17. Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G. Angeli, A. (2005) Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinology and Metabolism Clinics of North America, 34, 423 439, x.
18. Orentreich, N., Brind, J.L., Rizer, R.L. Vogelman, J.H. (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism, 59, 551 555.
19. Weiss, L.M., Medeiros, L.J. Vickery, A.L. Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. American Journal of Surgical Pathology, 13, 202 206.
20. Kannisto, S., Laatikainen, A., Taivainen, A., Savolainen, K., Tukiainen, H. Voutilainen, R. (2004) Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. European Journal of Endocrinology, 150, 687 690.
21. Newell-Price, J., Trainer, P., Besser, M. Grossman, A. (1998) The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews, 19, 647 672.
22. Boscaro, M., Barzon, L., Fallo, F. Sonino, N. (2001) Cushing's syndrome. Lancet, 357, 783 791.
23. Grumbach, M.M., Biller, B.M., Braunstein, G.D., Campbell, K.K., Carney, J.A., Godley, P.A., Harris, E.L., Lee, J.K., Oertel, Y.C., Posner, M.C., Schlechte, J.A. Wieand, H.S. (2003) Management of the clinically inapparent adrenal mass ('incidentaloma'). Annals of Internal Medicine, 138, 424 429.
24. Plouin, P.F., Amar, L. Chatellier, G. (2004) Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrology, Dialysis, Transplantation, 19, 774 777.
25. Stewart, P.M. (1999) Mineralocorticoid hypertension. Lancet, 353, 1341 1347.
26. Chanson, P., Pantel, J., Young, J., Couzinet, B., Bidart, J.M. Schaison, G. (1997) Free luteinizing-hormone beta-subunit in normal subjects and patients with pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 82, 1397 1402.
27. Suzuki, T., Sasano, H., Takeyama, J., Kaneko, C., Freije, W.A., Carr, B.R. Rainey, W.E. (2000) Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clinical Endocrinology, 53, 739 747.
28. Oelkers, W. (1996) Adrenal insufficiency. New England Journal of Medicine, 335, 1206 1212.
29. Sakai, Y., Yanase, T., Takayanagi, R., Nakao, R., Nishi, Y., Haji, M. Nawata, H. (1993) High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome associated with high secretion of adrenal androgens. Journal of Clinical Endocrinology and Metabolism, 76, 1286 1290.
30. Young, J., Couzinet, B., Nahoul, K., Brailly, S., Chanson, P., Baulieu, E.E. Schaison, G. (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. Journal of Clinical Endocrinology and Metabolism, 82, 2578 2585.
31. Bernini, G., Moretti, A., Iacconi, P., Miccoli, P., Nami, R., Lucani, B. Salvetti, A. (2003) Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology, 148, 213 219.
32. Racz, K., Pinet, F., Marton, T., Szende, B., Glaz, E. Corvol, P. (1993) Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and 'nonfunctioning' adrenal adenomas. Journal of Clinical Endocrinology and Metabolism, 77, 677 682.
33. Kim, M.S., Shigenaga, J., Moser, A., Grunfeld, C. Feingold, K.R. (2004) Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. American Journal of Physiology: Endocrinology and Metabolism, 287, E731 E738.
34. Couzinet, B., Meduri, G., Lecce, M.G., Young, J., Brailly, S., Loosfelt, H., Milgrom, E. Schaison, G. (2001) The postmenopausal ovary is not a major androgen-producing gland. Journal of Clinical Endocrinology and Metabolism, 86, 5060 5066.
35. Havelock, J.C., Rainey, W.E., Bradshaw, K.D. Carr, B.R. (2006) The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression. Human Reproduction, 21, 309 317.
36. Rainey, W.E., Carr, B.R., Sasano, H., Suzuki, T. Mason, J.I. (2002) Dissecting human adrenal androgen production. Trends in Endocrinology and Metabolism, 13, 234 239.
37. Auchus, R.J., Lee, T.C. Miller, W.L. (1998) Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. Journal of Biological Chemistry, 273, 3158 3165.
38. Sakai, Y., Yanase, T., Hara, T., Takayanagi, R., Haji, M. Nawata, H. (1994) Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas. Journal of Clinical Endocrinology and Metabolism, 78, 36 40.
39. Sakai, Y., Yanase, T., Hara, T., Takayanagi, R., Haji, M. Nawata, H. (1994) In-vitro evidence for the regulation of 17,20-lyase activity by cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome. Clinical Endocrinology, 40, 205 209.
40. Strott, C.A. (1996) Steroid sulfotransferases. Endocrine Reviews, 17, 670 697.
41. Simard, J., de Launoit, Y. Labrie, F. (1991) Characterization of the structure-activity relationships of rat types I and II, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase by site-directed mutagenesis and expression in HeLa cells. Journal of Biological Chemistry, 266, 14842 14845.
42. Wang, W., Yang, L., Suwa, T., Casson, P.R. Hornsby, P.J. (2001) Differentially expressed genes in zona reticularis cells of the human adrenal cortex. Molecular & Cellular Endocrinology, 173, 127 134.
43. Yanase, T., Sasano, H., Yubisui, T., Sakai, Y., T akayanagi, R. Nawata, H. (1998) Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing's syndrome. Endocrine Journal, 45, 89 95.
44. Dharia, S., Slane, A., Jian, M., Conner, M., Conley, A.J., Brissie, R.M. Parker, C.R. Jr (2005) Effects of aging on cytochrome b5 expression in the human adrenal gland. Journal of Clinical Endocrinology and Metabolism, 90, 4357 4361.
45. Bassett, M.H., Mayhew, B., Rehman, K., White, P.C., Mantero, F., Arnaldi, G., Stewart, P.M., Bujalska, I. Rainey, W.E. (2005) Expression profiles for steroidogenic enzymes in adrenocortical disease. Journal of Clinical Endocrinology and Metabolism, 90, 5446 5455.
46. Saner, K.J., Suzuki, T., Sasano, H., Pizzey, J., Ho, C., Strauss, J.F., 3rd, Carr, B.R. Rainey, W.E. (2005) Steroid sulfotransferase 2A1 gene transcription is regulated by steroidogenic factor 1 and GATA-6 in the human adrenal. Molecular Endocrinology, 19, 184 197.